Factors associated with no apparent coronary artery disease in patients with type 2 diabetes mellitus for more than 10 years of duration: a case control study

Association of insulin resistance and coronary artery remodeling: an intravascular ultrasound study

(2015) Sang-Hoon Kim et al.   Cardiovascular Diabetology

Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists

(2014) Francisco Kerr Saraiva et al.   Cardiovascular Diabetology

Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction

(2014) Thomas M. Maddox et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Insulin Resistance Induced by Hyperinsulinemia Coincides with a Persistent Alteration at the Insulin Receptor Tyrosine Kinase Domain

(2014) Karyn J. Catalano et al.   PLoS One

Usefulness of metabolic syndrome score in the prediction of angiographic coronary artery disease severity according to the presence of diabetes mellitus: relation with inflammatory markers and adipokines

(2013) Jong-Youn Kim et al.   Cardiovascular Diabetology

Metabolically obese status with normal weight is associated with both the prevalence and severity of angiographic coronary artery disease

(2013) Beom-June Kwon et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Association Between Insulin Resistance and Development of Microalbuminuria in Type 2 Diabetes: A prospective cohort study

(2011) C.-C. Hsu et al.   DIABETES CARE

INSULIN RESISTANCE IS ASSOCIATED WITH METABOLIC SYNDROME BUT NOT WITH ANGIOGRAPHICALLY DETERMINED CORONARY ARTERY DISEASE IN FEMALE PATIENTS

(2011) Alexander Vonbank et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Clinical Application of Incretin-Based Therapy: Therapeutic Potential, Patient Selection and Clinical Use

(2009) David M. Kendall et al.   AMERICAN JOURNAL OF MEDICINE

Usefulness of the SYNTAX Score for Predicting Clinical Outcome After Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease

(2009) Davide Capodanno et al.   Circulation-Cardiovascular Interventions

Effects of Intensive Glucose Lowering in Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE